[Federal Register Volume 86, Number 211 (Thursday, November 4, 2021)]
[Notices]
[Pages 60842-60843]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-23971]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Biodefense Science Board

AGENCY: Office of the Assistant Secretary for Preparedness and Response 
(ASPR), Department of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Biodefense Science Board (NBSB or the Board) is 
authorized under Section 319M of the Public Health Service (PHS) Act, 
as added by section 402 of the Pandemic and All-Hazards Preparedness 
Act of 2006 and amended by section 404 of the Pandemic and All-Hazards 
Preparedness Reauthorization Act. The Board is governed by the Federal 
Advisory Committee Act (5 U.S.C. app.), which sets forth standards for 
the formation and use of advisory committees. The NBSB provides expert 
advice and guidance on scientific, technical, and other matters of 
special interest to the Department of Health and Human Services (HHS) 
regarding current and future chemical, biological, nuclear, and 
radiological agents, whether naturally occurring, accidental, or 
deliberate. Authority to manage and operate the NBSB, including to 
receive advice and recommendations from the Board, has been delegated 
by the Secretary of HHS to the Assistant Secretary for Preparedness and 
Response (ASPR). The NBSB will meet in public (virtually) on December 
16, 2021, to provide advice and recommendations to ASPR regarding the 
development of the 2023-2026 National Health Security Strategy and to 
discuss other matters of current important for public health emergency 
preparedness, response, and recovery. A more detailed agenda will be 
available on the NBSB meeting website https://www.phe.gov/nbsb.
    Procedures for Public Participation: Members of the public may 
attend the meeting via a toll-free phone number or Zoom teleconference, 
which requires pre-registration. The meeting link to pre-register will 
be posted on the meeting website https://www.phe.gov/nbsb. Members of 
the public may provide written comments or submit

[[Page 60843]]

questions for consideration by the NBSB at any time via email to 
[email protected].
    Additionally, the NBSB invites those who are involved in or 
represent a relevant biodefense or health security industry, serve as 
faculty or conduct research at an academic institution, occupy a 
relevant health profession, or work for a hospital system or health 
care consumer organization; or those who serve in a state, Tribal, 
territorial or local government agency to request up to seven minutes 
to address the Board in person via Zoom. Requests to provide remarks to 
the NBSB during the public meeting must be sent to [email protected] by 
midnight on October 10, 2021. In that request, please provide the name, 
title, and position of the individual who will be speaking and a brief 
description of the planned topic. Presenters who are selected for the 
public meeting will have audio only during the meeting, thoughlides, 
documents, and other presentation material may be sent ahead; those 
will be provided directly to the board members. Topics and 
presentations with an obvious commercial bias, to include any form of 
advertising, marketing, or solicitation, will not be accepted.

FOR FURTHER INFORMATION CONTACT: CAPT Christopher L. Perdue, MD, MPH, 
(202) 480-7226, NBSB Designated Federal Officer, Washington, DC, Office 
[email protected].

Dawn O'Connell,
Assistant Secretary for Preparedness and Response.
[FR Doc. 2021-23971 Filed 11-3-21; 8:45 am]
BILLING CODE 4150-37-P